Literature DB >> 371793

Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.

A S Levine, M Sivulich, P H Wiernik, H B Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 371793

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  29 in total

Review 1.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 2.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

Review 3.  Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

Authors:  Jason R Baird; Arta M Monjazeb; Omid Shah; Heather McGee; William J Murphy; Marka R Crittenden; Michael J Gough
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-19       Impact factor: 7.038

Review 4.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group.

Authors:  B J Giantonio; H Hochster; R Blum; P H Wiernik; G R Hudes; J Kirkwood; D Trump; M M Oken
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

6.  The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.

Authors:  Hussein Sultan; Takumi Kumai; Toshihiro Nagato; Juan Wu; Andres M Salazar; Esteban Celis
Journal:  Cancer Immunol Immunother       Date:  2019-01-02       Impact factor: 6.968

Review 7.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

8.  Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.

Authors:  J Imanishi; M Matsubara; C J Won; H Nomura; T Kishida
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

9.  Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.

Authors:  Damià Tormo; Agnieszka Checińska; Direna Alonso-Curbelo; Eva Pérez-Guijarro; Estela Cañón; Erica Riveiro-Falkenbach; Tonantzin G Calvo; Lionel Larribere; Diego Megías; Francisca Mulero; Miguel A Piris; Rupesh Dash; Paola M Barral; José L Rodríguez-Peralto; Pablo Ortiz-Romero; Thomas Tüting; Paul B Fisher; María S Soengas
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

10.  Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.

Authors:  D A Stringfellow; S D Weed
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.